Many individuals consume fentanyl without their knowledge (because they do not realize that it is in a product they’re using), while others are intentionally using fentanyl because of its potency. It is partly responsible for the current overdose crisis in the U.S., combined with a lack of resources and the criminalization of people who use drugs. This fact sheet from the National Harm Reduction Coalition (NHRC) addresses some of the myths and lesser known facts about fentanyl.

This video explains the importance of primary care in treating substance use disorder, and how providers can work to decrease the stigma around treatment services.

Use this toolkit from the California Department of Public Health (CDPH) to share information about the risks of fentanyl and how to prevent overdose.

Access to naloxone isn’t just a funding issue. Barriers to accessing low-cost naloxone are a result of the decades-long war on drugs. This organization is working to eliminate barriers from three different angles: distribution, technical assistance, and research.

The Chicago Recovery Alliance (CRA) is a racially and ethnically diverse group composed of people living with HIV and drug use, working in addiction treatment, healthcare, education, law and other assorted areas. CRA is unique as an organization in that our work entails building one-on-one relationships with individuals affected by HIV and drug use and provide them with a wide array of options for achieving any positive change as they define it for themselves. CRA is an organization for those interested in directly serving, supporting, educating and advocating with others for reducing drug related harm.

This fact sheet makes the case for contingency management as a behavioral treatment option to addressing SUD. It explains some of the legal barriers to implementing contingency management on a wide scale, and why it is important to embrace methods other than medicine in our efforts.

This fact sheet answers ten FAQs regarding methamphetamines and their place in the addiction and overdose discussion.

Deaths due to illicit fentanyl and heroin are now leading drivers of the opioid epidemic. This document argues for stronger support from the federal government in providing resources to curb overdose-related deaths, such as MAT.

Despite data showing the success of MAT in treating drug addiction, objections are still common. This document helps clear up some common misconceptions about MAT, and brings evidence-based practice to the discussion around MAT.

This discussion guide is designed to help you talk with the teens around you about fentanyl in a way that empowers them to make safer choices.

As fentanyl has become ubiquitous across the U.S., it has transformed the illicit drug market and raised the risk of overdose. This article provides insight into how fentanyl has infiltrated the drug supply in America so quickly, and how we can prevent deaths moving forward.

This fact sheet from the Drug Enforcement Administration provides information about the origin and harmful effects of fentanyl.

This is the story of Bob and his experience with overcoming substance use disorder.

Founded in 2016, this international group provides is combatting the drug death crisis by empowering organizations and the general public with simple, cost-effective drug testing methods.

DanceSafe is a nonprofit that provides drug checking and is founded on social justice principles. They are known for testing users drugs at festivals and events and have additional programs ranging from drug education to consent deep-dives to political advocacy to sexual health. You can visit their site to learn more about their efforts or purchase drug testing products via their shop.

BTNX Inc. is a biotechnology company that specializes in rapid, point-of-care diagnostics. BTNX is the manufacturer of fentanyl testing strips which can be purchased directly from this manufacturer.

Santa Barbara Opioid Safety Coalition worked with Santa Maria Joint Union High School District to recently amend a local school policy surrounding medication administration to additionally include naloxone into the policy. This policy allows for the superintendent or designee, or any trained district staff member, to administer naloxone during an opioid overdose. This is an excellent showcase on how COPN coalitions are implementing policy change at the local level.

California Department of Public Health has a Harm Reduction and Syringe Access Division, focused on serving people who inject drugs. California law supports public health efforts to expand access to sterile syringes through both syringe exchange programs (SEPs, also known as syringe services programs) and nonprescription syringe sale in pharmacies.

CDPH has issued a statewide standing order to help reduce morbidity and mortality associated with opioid overdose by facilitating the distribution and administration of Naloxone Hydrochloride (Naloxone) in California.

In the U.S., drug overdose deaths have increased substantially during the COVID-19 pandemic. Synthetic opioids are implicated as the primary drivers of this increase. Naloxone is recommended for use and distribution by health professionals and laypersons to address this crisis. Given the relative potency of many synthetic opioids, it has been theorized that higher doses of naloxone may be required to effectively reverse overdoses. This study tests that theory and provides recommendations related to naloxone prescriptions.